Raymond James Begins Coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ)

Raymond James assumed coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a research report sent to investors on Thursday morning, Marketbeat reports. The firm issued a market perform rating on the specialty pharmaceutical company’s stock. Several other equities research analysts have also issued reports on JAZZ. Royal Bank of Canada dropped their […]

Related Keywords

Canada ,United States ,America ,Ricke Winningham ,Raymond James ,Neenam Patil ,Royal Bank ,V Square Quantitative Management ,Institutional Investors Weigh In On Jazz Pharmaceuticals ,Jazz Pharmaceuticals ,St Germaindj Co ,Needham Company ,News Ratings For Jazz Pharmaceuticals Daily ,Securities Exchange Commission ,Jazz Pharmaceuticals Stock Down ,Cantor Fitzgerald ,Analyst Recommendations For Jazz Pharmaceuticals ,Quadrant Capital Group ,Nasdaq ,Free Report ,Pharmaceuticals Stock Down ,Get Free Report ,Director Rick ,Exchange Commission ,Wealth Management ,Square Quantitative Management ,Capital Group ,Jazz Pharmaceuticals Daily ,Nasdaq Jazz ,Jazz ,Medical ,G5087110 ,Initiated Coverage ,